Delivery Order SPE2DR25D2104-SPE2DR26F3TFG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count units) with a ceiling value of $3,417.46. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Icosapent Ethyl 1 Gram Capsule 120-count units, with a contract ceiling value of $3,250.80. This non-set-aside award was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, utilizing firm fixed pricing under a delivery order contract type. The pharmaceutical product will be performed at AmerisourceBergen's facility located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count). This is a non-set-aside, competitively awarded delivery order with a firm fixed price ceiling of $2,645.61 and an ultimate completion date of December 1, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,229.78 for the pharmaceutical product Icosapent Ethyl 1 gram capsules. The contract was awarded by the Defense Logistics Agency (DLA) on January 20, 2023, with a completion date of January 23, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which...
- This federal contract award, valued at $2,664.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Icosapent Ethyl 1 gram capsules (120 count). The award has a completion date of January 31, 2023 and is structured as a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization registered in the System for Award...
- This federal contract award, valued at $1,232.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- The federal contract award SPE2DB20D3505|SPE2DB23FT6H4 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,412.31 fixed-price delivery order is for the supply of 4559771141 - Icosapent Ethyl 1 Gram Capsule 120s, with a completion date of January 31, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Omega-3 Ethyl Esters 1 GM capsules (120-count supply) on November 17, 2025, with a ceiling value of $1,072.87. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by November 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Omega-3 Ethyl Esters 1 GM capsules (120 count) with a ceiling value of $2,239.84 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility and an ultimate completion date of September 5, 2025. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,122.24 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OMEGA-3 ETHYL ESTERS 1 GM CAP 120S pharmaceutical products. The contract has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is the sole awardee on this delivery order and there is no set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TFGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,696.86 to AmerisourceBergen Drug Corp for the supply of Icosapent Ethyl 1 gram capsules (120-count units) with a firm fixed-price structure. The contract is non-set-aside and competitively awarded, with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of January 12, 2026. This delivery order operates under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for pharmaceutical and medical supply delivery to military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor within the federal medical procurement system, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. The DLA Troop Support Medical prime vendor contract encompasses comprehensive global pharmaceutical support, enabling efficient fulfillment of essential medical commodities required by military treatment facilities and veterans' healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 1/8/26 |